Skip to content

Archives of Neurology And Psychiatry

ISSN 0096-6754

9 papers in the library · 1,229 citations · publishing 1941-1959

Papers

Sort Most recent Most cited

Use of Lysergic Acid Diethylamide in a Psychotherapeutic Setting

Archives of Neurology And Psychiatry May 1, 1959 Sidney Cohen 49 citations

In experimental psychiatry the hallucinogenic drugs have a firmly established position; hundreds of articles attest to the growing interest in their psychotomimetic activity. As an adjunct to psychotherapy, however, their potential has been incompletely investigated. The initial mention of lysergic acid diethylamide (LSD-25) in this connection appears to be the 1950 publication by Busch and...

Study of a New Schizophrenomimetic Drug—Sernyl

Archives of Neurology And Psychiatry March 1, 1959 Elliot D. Luby 920 citations

Introduction The production of model psychoses has been employed as a technique for testing hypotheses relevant to the causes, correlates, and treatment of schizophrenia since 1921, when De Jong demonstrated experimental catatonia by giving bulbocapnine to animals.5This method of study has received considerable impetus with the discovery of the hallucinogenic properties of lysergic acid...

Effects of Lysergic Acid Diethylamide (LSD-25) on Intellectual Functions

Archives of Neurology And Psychiatry October 1, 1958 A. B. Silverstein 30 citations

I. MemoryIntroduction. —The results of previous studies of the effect of lysergic acid diethylamide (LSD-25) on memory suggest that the minimal dose level at which impairment becomes evident lies somewhere between 50μg. and 100μg. Sloane and Lovett Doust,1working at the 40μg. level, and Jarvik et al.,2working at the 50μg. level, found little or no evidence of memory impairment in their studies....

Analeptic Action of Lysergic Acid Diethylamide (LSD-25) Against Pentobarbital

Archives of Neurology And Psychiatry June 1, 1958 Julia T. Apter 9 citations

Adventitious findings in this laboratory indicate that lysergic acid diethylamide (LSD-25) protects cats against the toxic effects of large doses of pentobarbital. One hundred forty cats have survived inordinate amounts of pentobarbital at the termination of experiments in which LSD-25 solution was given systemically. Gastaut,13Bradley,3,4and others6,8,14,18provide electrophysiological evidence...

Progression of Effects of Lysergic Acid Diethylamide [LSD]

Archives of Neurology And Psychiatry July 1, 1956 Santo Salvatore 29 citations

Introduction Since the Swiss chemist Hoffman, on April 16, 1943, accidentally discovered the mental effects of lysergic acid diethylamide (LSD-25), a great many experiments with the drug have been reported in various journals. Observations show most agreement in the area of physical subjective symptoms and unreality and least agreement in changes of mood and behavior. Tremor, nausea, dilation...

Effects of Mescaline, LSD-25, and Adrenochrome on Depth Electrograms in Man

Archives of Neurology And Psychiatry June 1, 1956 Bert E. Schwarz 49 citations

In a recent report concerning the reversibility by chlorpromazine of psychoses induced by means of mescaline andd-lysergic acid diethylamide (LSD-25), careful attention was given to the clinical and electroencephalographic changes.1Although the clinical changes of this reversal effect were immediate and striking, the conventional electroencephalographic changes were minimal, and it was...

Some Effects of Bufotenine and Lysergic Acid Diethylamide on the Monkey

Archives of Neurology And Psychiatry 1956 Edward V. Evarts 52 citations

INTRODUCTION Bufotenine (5 -hydroxy -3 -[2- dimethyl-aminoethyl]-indole) is the N-dimethyl derivative of the vasoconstrictor substance serotonin (5-hydroxytryptamine). It was first synthesized by Wieland in 1934. Raymond-Hamet found that intravenous injection of bufotenine caused transient elevation of blood pressure and apnea, followed by tachypnea, in anesthetized dogs.* To date, however,...

EXPERIMENTAL PHYSIOLOGICAL STUDIES WITH LYSERGIC ACID DIETHYLAMIDE (LSD-25)

Archives of Neurology And Psychiatry May 1, 1951 Gordon R. Forrer 66 citations

STOLL1studied the effects of lysergic acid diethylamide (LSD-25) in both psychotic and normal subjects. Condrau2and others reported their results of administration of lysergic acid diethylamide to various types of subjects and in general confirmed the findings of Stoll. For details of the chemistry of the ergot alkaloids, we refer to a more recent, comprehensive work by Stoll.3It should be...

MESCALINE HALLUCINATIONS IN ARTISTS

Archives of Neurology And Psychiatry 1941 W. S. Maclay 25 citations

The various theories about the cause of hallucinations have been largely influenced by the material which the writers studied. Thus, Mayer-Gross formed his theory on observation of the fantom limb, Schroeder on observation of delirious states and Vogt on experience with electrical stimulation of the cerebral cortex. It lies in the nature of the subject that its study is based mainly on verbal...